Stephen Basil Thomas - Director at Eliem Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
ELYM on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Stephen Basil Thomas since 9/17/2023

Holdings reported by Stephen Basil Thomas for Eliem Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 104K $750K $7.21 Jun 27, 2024 Direct
Restricted Stock Units 100K $724K $7.21 Jun 27, 2024 Direct Common Stock

Transactions reported by Stephen Basil Thomas for Eliem Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.